The present invention provides novel formula (I) compound, pharmaceutically acceptable salt and its pharmaceutical composition, and described pharmaceutical composition is suitable for treatment by the ROR γ disease mediated and illness. Pharmaceutical composition comprising described novel formula (I) compound is also provided and it treats the method in one or more inflammation, metabolism, autoimmunity and Other diseases or illness with what.本發明提供新穎式(I)化合物,其藥學上可接受的鹽,和其藥物組合物,所述藥物組合物適用於治療通過RORγ介導的疾病和病症。還提供包含所述新穎式(I)化合物的藥物組合物和其用於治療一或多種發炎、代謝、自身免疫和其它疾病或病症中的方法。